###begin article-title 0
Progressive loss of CD3 expression after HTLV-I infection results from chromatin remodeling affecting all the CD3 genes and persists despite early viral genes silencing
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 19 21 19 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 65 67 65 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 73 77 73 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
HTLV-I infected CD4+ T-cells lines usually progress towards a CD3- or CD3low phenotype. In this paper, we studied expression, kinetics, chromatin remodeling of the CD3 gene at different time-points post HTLV-I infection.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 58 61 58 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 119 122 115 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 134 137 126 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 149 152 135 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 214 217 197 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 255 257 234 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 549 552 528 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 562 565 537 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 589 592 560 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 905 913 868 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 959 962 922 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
The onset of this phenomenon coincided with a decrease of CD3gamma followed by the subsequent progressive reduction in CD3delta, then CD3epsilon and CD3zeta mRNA. Transient transfection experiments showed that the CD3gamma promoter was still active in CD3- HTLV-I infected cells demonstrating that adequate amounts of the required transcription factors were available. We next looked at whether epigenetic mechanisms could be responsible for this progressive decrease in CD3 expression using DNase I hypersensitivity (DHS) experiments examining the CD3gamma and CD3delta promoters and the CD3delta enhancer. In uninfected and cells immediately post-infection all three DHS sites were open, then the CD3gamma promoter became non accessible, and this was followed by a sequential closure of all the DHS sites corresponding to all three transcriptional control regions. Furthermore, a continuous decrease of in vivo bound transcription initiation factors to the CD3gamma promoter was observed after silencing of the viral genome. Coincidently, cells with a lower expression of CD3 grew more rapidly.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
We conclude that HTLV-I infection initiates a process leading to a complete loss of CD3 membrane expression by an epigenetic mechanism which continues along time, despite an early silencing of the viral genome. Whether CD3 progressive loss is an epiphenomenon or a causal event in the process of eventual malignant transformation remains to be investigated.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 911 912 907 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1008 1009 1004 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1010 1011 1006 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1035 1037 1031 1033 <sup xmlns:xlink="http://www.w3.org/1999/xlink">I </sup>
###xml 1166 1167 1162 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1168 1169 1164 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1272 1273 1268 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
HTLV-I infection can lead to the development of adult T-cell leukemia/lymphoma (ATLL) in 2-5% of infected individuals depending upon geographic location and exposure to etiologic factors. It is currently thought that tumors develop from a persistently infected T-cell reservoir, which can be amplified by cytokine-induced activation leading to viral gene expression, cellular proliferation and survival of some expanded cells. Viral gene expression has been implicated in the disruption of various normal cellular processes, including activation, growth, and apoptosis, the latter allowing accumulation of abnormalities leading to cellular transformation. Several viral proteins have been shown to play an important role in tumor progression by modulating transcription factors. The pleiotropic viral protein Tax mediates the NF-kappaB activation resulting in abnormal cytokine and cytokine receptor expression[1]. Sumoylation and ubiquitination of Tax are critical for Tax mediated transcriptional activity[2,3]. The viral protein p12I stimulates calcium release from the endoplasmic reticulum, which induces NFAT transcription factors leading to T-cell activation[4,5]. The viral protein HBZ represses c-Jun mediated transcription by inhibiting its DNA binding activity[6].
###end p 9
###begin p 10
###xml 105 107 105 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 175 177 175 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 183 187 183 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 198 199 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 200 201 200 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 758 760 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 130 138 <span type="species:ncbi:9606">patients</span>
A keystone of the antigen-specific immune response is the T-cell receptor (TCR)/CD3 complex. Infected CD4+ lines and T-cells from patients with ATLL are characterized by a CD3- or CD3low phenotype [7-9]. In a previous work[10] we have shown that HTLV-I infected cells acquired a profound decrease of intracellular calcium levels in response to ionomycin, timely correlated with decreased CD7 and CD3 expression. This perturbation induced Akt and Bad phosphorylation via activation of PI3K. The activation of the Akt/Bad pathway generates a progressive resistance to apoptosis, at a time HTLV-I genes expression is silenced. Since dysregulation of calcium flux after T-cell activation has been suggested as a possible consequence of absence of CD3 expression[11]. We decided to investigate the mechanisms responsible for the loss of CD3 expression, its kinetics and its timely relationship with viral gene expression.
###end p 10
###begin p 11
###xml 29 31 29 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3 </italic>
###xml 141 143 141 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 179 188 179 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 411 413 411 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 483 485 483 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 488 490 488 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 583 586 583 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 426 431 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 441 446 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 466 474 <span type="species:ncbi:9606">patients</span>
Experimental infection of CD4+ T cells with HTLV-I was known to progressively downregulate CD3 genes transcripts, eventually leading to a CD3- surface phenotype after 200 days of in vitro infection [12,13]; however, the sequence of CD3 genes loss of expression had not been investigated. Previous data from our laboratory showed that CD3 membrane expression was downmodulated after experimental infection of CD4+ T cells with HIV-1 [14-17], HIV-2[18], as well as in patients with CD3- CD4+ T-cell lymphoma mediated hypereosinophilic syndrome [19], all linked to a specific defect in CD3gamma gene transcripts. All T-lymphotropic viruses induce CD3 downregulation in the absence of a generalized suppression of host protein synthesis.
###end p 11
###begin p 12
###xml 51 53 51 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 310 313 310 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 364 366 360 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 411 414 407 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 509 512 501 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 519 522 507 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 534 537 516 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
The HTLV LTR responds to T cell-activation signals[20], which suggests an important relationship between the regulation of viral gene transcription and the TCR/CD3-controlled antigen activation pathway. This study demonstrates that HTLV-I associated loss of CD3 expression is also linked to an initial loss of CD3gamma gene transcripts, ultimately leading to a CD3- phenotype. However, we show that the initial CD3gamma transcripts decrease is followed by a subsequent progressive and sequential reduction in CD3delta, CD3epsilon and CD3zeta genes transcription, going on after early viral genes silencing. Our experiments also demonstrate that these phenomena occur through chromatin remodeling and progressive closure of the CD3 genes promoter sites and are not the results of transcription factors depletion. Finally, this loss of CD3 expression is timely associated with a growth advantage, but further experiments will be needed to determine whether there is a causal relationship between these two observations.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
Cell culture conditions and reagents
###end title 14
###begin p 15
###xml 51 53 51 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 27 32 <span type="species:ncbi:9606">human</span>
###xml 142 148 <span type="species:ncbi:9913">bovine</span>
###xml 248 253 <span type="species:ncbi:9606">human</span>
###xml 399 406 <span type="species:ncbi:9606">patient</span>
###xml 541 546 <span type="species:ncbi:9606">human</span>
###xml 596 601 <span type="species:ncbi:9606">Human</span>
###xml 827 833 <span type="species:ncbi:9913">bovine</span>
The WE17/10 cell line is a human IL-2 dependent CD4+ T cell line[14] that was established and is maintained in RPMI 1640 containing 20% fetal bovine serum, 1.25 mM L-glutamine, 0.55 mM L-arginine, 0.24 mM L-asparagine, and 100 units of recombinant human IL-2 per ml. The MT-2 cell line was derived by co-culturing normal umbilical cord leukocytes with donor leukemic T-cells from an HTLV-I infected patient [21]. WE17/10 cells were co-cultured with irradiated MT-2 cells at a ratio of 1:1 to generate HTLV-I infected WE17/10 cell lines. The human B lymphocyte line, GM-607, was obtained from the Human Genetic Cell Repository run by Coriell Institute, Camden NJ). The HTLV-1-transformed T-cell lines (C91-PL, MT-2), were obtained from MT-2, C91-PL and GM-607 cell lines were maintained in RPMI 1640 supplemented with 10% fetal bovine serum and ATL-derived culture (PaBe).
###end p 15
###begin title 16
Southern blot
###end title 16
###begin p 17
###xml 78 80 78 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">co</italic>
###xml 121 123 121 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ac</italic>
###xml 332 335 332 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kpn</italic>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 403 407 403 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pro </italic>
###xml 430 434 430 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
We used a standard southern blot protocol. The genomic DNA was digested with EcoRI (no cut into the HTLV-I provirus) or SacI (cut once into the HTLV-I LTR) and electrophoresed in an agarose gel then transferred to nylon membrane (Amersham International, Buckinghamshire, UK). The filters were hybridized with radiolabeled probe : a KpnI fragment[22], corresponding to a 2.9 kb fragment beginning in the pro gene and ending in the env gene, at 65degreesC for 12 hours, washed in buffers, and then exposed to X-ray film at -80degreesC.
###end p 17
###begin title 18
Flow Cytometry
###end title 18
###begin p 19
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 131 137 <span type="species:ncbi:10090">murine</span>
###xml 371 375 <span type="species:ncbi:9925">goat</span>
###xml 381 386 <span type="species:ncbi:10090">mouse</span>
Cells were analyzed for CD3 surface expression by flow cytometry as previously described[17]. Briefly, cells were labeled with the murine monoclonal antibody Leu4a (BD Biosciences, Erembodegen, Belgium) in a two-step process using 1 mug/ml of the primary antibody to ensure saturation binding followed by the manufacturer's recommended dilution of fluorescein-conjugated goat anti-mouse immunoglobulin (BD Biosciences). The labeled cells were fixed in 2% paraformaldehyde, and fluorescence was analyzed on a FACS Caliber (BD Biosciences).
###end p 19
###begin title 20
Transient transfection
###end title 20
###begin p 21
###xml 186 188 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 189 191 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
WE17/10 cells (uninfected and HTLV-I infected) were transiently transfected using standard DEAE-dextran protocols with wild-type (pHgamma3-wt) promoter construct as previously described[17,23].
###end p 21
###begin title 22
Identification of Dnase I hypersensitive sites
###end title 22
###begin p 23
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 206 207 206 207 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 398 399 398 399 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 473 475 473 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
Isolation and DNase I digestion of nuclei was performed using a method previously described [24]. Briefly, the cells were washed in PBS and resuspended in cell lysis buffer (60 mM KCl, 15 mM NaCl, 5 mM MgCl2, 10 mM Tris pH 7.4, 300 mM sucrose, 0.1 mM EGTA, and 0.1% NP-40) to isolate the nuclei. The nuclei were then resuspended in 1 ml of nuclear digestion buffer (60 mM KCl, 15 mM NaCl, 5 mM MgCl2, 10 mM Tris pH 7.4, 300 mM sucrose, and 0.1 mM EGTA). Nuclei from 20 x 106 cells were digested for 3 minutes at 22degreesC using increments of DNase I (Roche Diagnostics) from 0 to 28 U/ml. The reaction was stopped by adding nuclear lysis buffer (300 mM sodium acetate, 5 mM EDTA pH 7.4, 0.5% SDS) containing 0.1 mg/ml proteinase K and incubating for 5 min at 55degreesC then overnight at 37degreesC. Genomic DNA was subsequently isolated using standard phenol chloroform extraction techniques.
###end p 23
###begin p 24
###xml 43 46 43 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 76 79 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 111 114 103 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
Genomic DNA was digested with BglI for the CD3delta promoter, BamHI for the CD3delta enhancer and SacI for the CD3gamma promoter prior to standard Southern blot analysis. Promoter probes were amplified by PCR using the following primer pairs:
###end p 24
###begin p 25
###xml 0 19 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3&#947; promoter: </italic>
CD3gamma promoter: forward, 5'-CACCTGCTGAAACTGAGCTG-3', reverse, 5'-TCCCAGACAGTGGAGGAGTT-3';
###end p 25
###begin p 26
###xml 0 18 0 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3&#948;promoter: </italic>
CD3deltapromoter: forward, 5'-GTTCCTCTGACAGCCTGAGC-3' and reverse 5'-TTTTAGGCCTGATGGCCTCT-3'.
###end p 26
###begin p 27
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 79 82 75 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 73 78 <span type="species:ncbi:9606">human</span>
The probe used to detect the CD3delta enhancer was a BamHI digest of the human CD3delta cDNA (NCBI accession # BC070321).
###end p 27
###begin title 28
RT-PCR
###end title 28
###begin p 29
###xml 336 340 329 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3 </italic>
###xml 377 379 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 380 382 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
Total RNA was isolated from cells using the TriPure Isolation Reagent (Roche Applied Science) in a single-step extraction method. Standard reverse transcription was performed using 1 mug of total RNA at 42degreesC for 45 minutes and 50 ng of the resulting cDNA was used per PCR reaction. The primer pairs used to amplify the individual CD3 genes have been previously described[25,26] and are as follows:
###end p 29
###begin p 30
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
CD3gamma: forward 5'-CATTGCTTTGATTCTGGGAACTGAATAGGAGGA-3', reverse 5'-GGCTGCTCCACGCTTTTGCCGGAGACAGAG-3';
###end p 30
###begin p 31
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
CD3delta: forward 5'-TTCCGGTACCTGTGAGTCAGC-3', reverse 5'-GGTACAGTTGGTAATGGCTGC-3'.
###end p 31
###begin title 32
Quantitative real-time RT-PCR
###end title 32
###begin p 33
###xml 426 431 401 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 432 434 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
Real-time RT-PCR was performed using a TaqMan Gene Expression Assay for each of the individual CD3 genes (CD3zeta HS00609512, CD3epsilon HS00167894, CD3gamma HS00173941 and CD3delta HS00174158; Applied Biosystems, Lennik, Belgium). Eukaryotic translation elongation factor1 alpha(EF-1-alpha) and cancer susceptibility candidate 3 (MLN51) were used as CD4+ T cell specific endogenous reference genes as described by Hamalainen et al[27]. Relative quantification was used to compare the changes in CD3 mRNA levels using the endogenous genes (EF-1-alpha and MLN51) as a normalizer and uninfected WE17/10 cells as a calibrator. The individual CD3 genes were normalized to the endogenous controls and the values are expressed as the quantity relative to the uninfected WE17/10 cell line. Biological duplicates were performed for all genes tested.
###end p 33
###begin title 34
EMSA
###end title 34
###begin p 35
###xml 42 44 42 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7 </sup>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 237 238 233 234 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1</bold>
###xml 237 238 233 234 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><bold>1</bold></sub>
###xml 272 273 260 261 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1</bold>
###xml 272 273 260 261 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><bold>1</bold></sub>
###xml 285 287 269 271 <bold xmlns:xlink="http://www.w3.org/1999/xlink">wt</bold>
###xml 285 287 269 271 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><bold>wt</bold></sub>
###xml 318 320 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
Nuclear extracts were prepared from 2 x 107 cells, and EMSA experiments were performed as described previously[17]. The radiolabeled oligonucleotide probe used for nuclear protein binding was an oligonucleotide encoding wild-type Spgamma1/CD3gammaInr binding site: Spgamma1/CD3gammaInrwt, 5'-GTGATGGGTGGAGCCAGTCTAG-3'[23]. The oligonucleotide bound complexes were separated on a 6% Tris-glycine-EDTA polyacrylamide gel migrated overnight at 50 V, and the radiolabeled protein complexes were detected by autoradiography.
###end p 35
###begin title 36
Chromatin immunoprecipitation (ChIP) assay
###end title 36
###begin p 37
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 749 750 739 740 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1</bold>
###xml 749 750 739 740 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><bold>1</bold></sub>
###xml 760 763 746 749 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Inr</sub>
###xml 776 778 758 760 <bold xmlns:xlink="http://www.w3.org/1999/xlink">2 </bold>
###xml 776 778 758 760 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><bold>2 </bold></sub>
###xml 476 482 <span type="species:ncbi:9986">rabbit</span>
The ChIP assay was performed as previously described[28] using the kit purchased from Upstate Biotechnology generally following the manufacturer's protocol. Uninfected and HTLV-I-infected WE17/10 cells were fixed with 1.5% formaldehyde for 10 min at 37degreesC. Chromatin was isolated, sheared using a Bioruptor (Diagenode), and immunoprecipitated with Abs directed to ac-H4, HDAC1, Sp1 (SC-59X), Sp3 (SC-644X), TFIID (SC-204X) (all from Santa Cruz Biotechnology), or control rabbit IgG (Upstate Biotechnology). Cross-linking was reversed by heating, and the proteins were removed subsequently by proteinase K digestion. The presence of selected DNA sequences in the immunoprecipitated DNA was assessed by PCR using the following primer pair Spgamma1, CD3gammaInr, and Spgamma2 (205-bp product), forward, 5'-GGGTTCTTGCCTTCTCTCTCAA-3', reverse, 5'-CCCCTAGTAGGCCCTTACCTT-3'.
###end p 37
###begin p 38
###xml 14 16 14 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
The amplified 32P-labeled PCR product was separated on a 6% acrylamide gel and detected by autoradiography.
###end p 38
###begin title 39
Results
###end title 39
###begin title 40
CD3 loss after HTLV-I infection is linked to a sequential reduction in CD3 gene transcripts
###end title 40
###begin p 41
###xml 55 57 55 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 447 452 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KpnI </italic>
###xml 488 492 488 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pro </italic>
###xml 515 519 515 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
The cell lines were derived from the IL-2 dependent CD4+ T cell line WE17/10 infected by the HTLV-I viruses produced by the MT-2 cell line. The latter, used as virus source, contains 8 complete or defective proviral genomic integrations some defective proviral genomes being able to produce viral RNA transcripts. The most dominant species of unintegrated viral DNA was 3.7 kb in size; it hybridized to a full-length HTLV-1 DNA probe but not to a KpnI viral DNA fragment beginning in the pro gene and ending in the env gene[29] that is absent from a defective proviral genome that has been previously identified in MT-2 cells.
###end p 41
###begin p 42
###xml 23 26 23 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
At 2 months p.i. using EcoRI, which does not cut within the 9 kb of the HTLV-I genome, the complete provirus probe revealed a smear witnessing a polyclonal integration of the provirus in the WE17/10 infected cells (Figure 1A).
###end p 42
###begin p 43
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3 </italic>
###xml 0 127 0 127 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Proviral integration, CD3 surface expression and relative <italic>CD3 </italic>gene expression over time after HTLV-I infection of WE17/10 cells</bold>
###xml 129 130 129 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 322 324 322 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">co</italic>
###xml 328 329 328 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 336 338 336 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pn</italic>
###xml 423 425 423 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ac</italic>
###xml 428 429 428 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 436 438 436 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pn</italic>
###xml 523 525 523 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">co</italic>
###xml 625 626 625 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 961 965 961 965 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 1151 1154 1151 1154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi </sup>
###xml 1226 1228 1226 1228 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1293 1294 1293 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1334 1338 1334 1338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3 </italic>
###xml 1480 1482 1480 1482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Proviral integration, CD3 surface expression and relative CD3 gene expression over time after HTLV-I infection of WE17/10 cells. A, HTLV-I proviral genome analyses of WE/HTLV cell line by Southern blot. the complete provirus probe was hybridized to the WE/HTLV (at 3 weeks, 4 and 7 months p.i.) genomic DNA digested with EcoRI. B, the KpnI fragment probe was hybridized to the (at 7 months p.i.) genomic DNA digested with SacI. C, the KpnI fragment probe was hybridized to the (at 7 months p.i.) genomic DNA digested with EcoRI. MT-2 and uninfected WE17/10 cell lines were used as positive and negative control respectively. D, TCR/CD3 surface expression over time after HTLV-I infection of WE17/10 cells. profiles showing the distribution of immunofluorescence from anti-CD3 antibody staining in a parallel antibody labeling experiment. Uninfected and HTLV-I infected cells were thawed from the frozen cell line bank at 5, 10, 40, 48, and 58 weeks p.i. TCR/CD3low cells are identified as cells that fall below the minimum fluorescence intensity defined by the positive control but do not lie within the region defined by the negative control. TCR/CD3hi cells fall within the region defined by mock-infected cells, and TCR/CD3- cells fall within the region designated by the negative control. E, Histograms representation of relative CD3 gene expression in HTLV-I infected cells at various times p.i. determined by real time RT-PCR in relation to the percentage of surface TCR/CD3+ cells determined by flow cytometry. All percentages were calculated relative to uninfected cells (100% positive). GM-607 B cell line was used as a negative control.
###end p 43
###begin p 44
###xml 227 230 227 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kpn</italic>
###xml 314 316 314 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ac</italic>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 383 386 383 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kpn</italic>
###xml 428 430 428 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">co</italic>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 579 582 579 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kpn</italic>
At 4 months p.i. the same experiment showed three bands of 18, 14 and 11 kb. At 7 months p.i. Only the 18 an 14 kb bands were evident suggesting at that time a biclonal proliferation of infected cells in the culture. Using the KpnI fragment as probe we detected a 9 kb band when the genomic DNA was digested with SacI, an enzyme cutting once in each HTLV-I LTR (Figure 1B). The same KpnI probe revealed an 18 Kb fragment after EcoRI DNA digestion (Figure 1C). Our data suggests that a WE17/10 clone, harboring one complete and one incomplete HTLV-I provirus, not detected by the KpnI probe, has a significant growth advantage. This is in accordance with the fast growing cultures observed later on.
###end p 44
###begin p 45
###xml 57 59 57 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 65 69 65 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 80 81 80 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 82 83 82 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 115 117 115 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 391 393 391 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 399 403 399 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 430 431 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 5 13 <span type="species:ncbi:9606">patients</span>
ATLL patients are routinely characterized as having a CD3- or CD3low phenotype [7-9]. Experimental infection of CD4+ T cells with HTLV-I and HTLV-II[12,13] has also been associated with defects in TCR/CD3 expression and function. We have tested the HTLV-I infected cell lines MT-2, C91, WE/HTLV and an ATLL derived cell line PaBe for their TCR/CD3 surface expression. All the cells had a CD3- or CD3low phenotype (Additional file 1).
###end p 45
###begin p 46
###xml 489 493 489 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
For WE/HTLV we have studied the kinetics of the CD3 surface expression loss. Initially, during the acute phase of infection, cell growth was slowed down by virus production and a significant cytopathic effect. At this time, assessment of TCR/CD3 surface expression by flow cytometry was difficult. Chronically infected cells, appearing around 3 weeks p.i., returned to a normal growth rate and expressed CD3 levels similar to the mock-infected control until 5 weeks p.i., the time when CD3low expressing cells first emerged.
###end p 46
###begin p 47
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 353 357 353 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 425 429 425 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 682 685 682 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi </sup>
###xml 691 695 691 695 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 701 702 701 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 780 782 780 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 783 785 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 786 788 786 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 873 876 873 876 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi </sup>
###xml 761 764 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Cryopreserved cells from different stages of the primary infection were thawed and CD3 surface density was quantified in a parallel experiment to ensure that the detected changes were not attributable to variation in antibody labeling experiments (Figure 1D). A significant reduction in CD3 density on the infected cell surface, corresponding to the CD3low phenotype, was detected at 6 to 10 weeks p.i. The cells remained CD3low until receptor negative cells began to emerge around 7 months p.i. followed by the complete loss of surface expression at approximately one year p.i. Thus, CD3 expression on chronically HTLV-I infected cells (WE/HTLV) decreased in a progression from CD3hi to CD3low to CD3-, similar albeit slower than that previously described for HIV-infected cells[14,15,18]. The mock-infected cells, carried in parallel passages, continuously maintained CD3hi expression.
###end p 47
###begin p 48
###xml 17 19 17 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 65 68 65 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 133 141 116 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 332 334 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 335 337 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 349 351 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 387 390 370 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 445 448 424 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 326 331 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 343 348 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
A previous study[13] found that all four CD3 chains transcripts (CD3gamma, delta, epsilon and zeta) were lost after HTLV-I infection in vitro, but these experiments did not provide insight into the order of their loss. Our previous experiments have shown that TCR/CD3 surface receptors are down-modulated after infection with HIV-1[14,17] and HIV-2[18] linked to an initial reduction in CD3gamma gene transcripts. We therefore asked whether the CD3gamma gene was also initially targeted after HTLV-I infection and found that its specific decrease of transcription precedes the progressive loss of surface CD3 expression on HTLV-I infected cells.
###end p 48
###begin p 49
###xml 175 178 175 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 204 206 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1E</xref>
###xml 263 266 259 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 273 276 265 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 286 289 274 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 384 386 366 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 492 495 474 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 599 602 577 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 665 668 639 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 733 736 701 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 794 797 758 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 870 873 830 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 885 888 839 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 930 938 881 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 997 1000 948 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 1017 1020 964 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 1052 1055 995 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 1067 1070 1004 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 1115 1116 1045 1046 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1121 1123 1047 1049 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1181 1184 1107 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 1191 1194 1113 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 1204 1207 1122 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 1257 1260 1169 1172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
A real time RT-PCR assay for quantification of all four CD3 gene transcripts revealed that the loss of TCR/CD3 complex at the cell surface occurs quite later than the loss of CD3gamma transcripts (Figure 1E). Initially, at 5 weeks p.i. there is a 25% decrease in CD3gamma, CD3delta and CD3epsilon transcripts observed in infected cells, shown by flow cytometry to express ~95% TCR/CD3+ surface complexes (relative to the uninfected controls). Subsequently, a precipitous drop of about 80% in CD3gamma transcripts appears while the density of the TCR/CD3 on the cell surface is ~70%. This erosion in CD3gamma transcript numbers progresses until all of the cells are CD3gamma and surface CD3 negative (+/- 9-12 mo. p.i.). This loss of CD3gamma gene expression is followed by a steady decrease in CD3delta transcripts followed by a slower but also progressive reduction in CD3epsilon and CD3zeta transcripts. Maintained continuously in vitro, the HTLV-I infected cells eventually become negative for CD3delta as well as CD3gamma transcripts. The level of CD3epsilon and CD3zeta transcripts remains ~25% in the CD3gamma-delta- cells even after more than three years p.i. In MT-2 cells CD3gamma, CD3delta and CD3epsilon transcripts are completely lost while the CD3zeta transcripts are still expressed but at a very low level (data not shown).
###end p 49
###begin title 50
###xml 45 47 41 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
The CD3gamma promoter can be activated in CD3- HTLV-I infected WE17/10 cells
###end title 50
###begin p 51
###xml 44 47 44 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 118 121 114 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 200 202 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 242 243 230 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 414 417 382 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 585 588 549 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 653 656 613 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 742 745 698 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
In an effort to investigate the full-length CD3gamma promoter activity in the HTLV-I infected cells after the loss of CD3gamma gene expression we used our previously described construct (pHgamma3-wt)[23] in a transient reporter assay (Figure 2). pHgamma3-wt was transfected into uninfected and HTLV-I infected WE17/10 cells. Interestingly, in CD3gamma-delta+ and CD3gamma-delta- HTLV-I infected WE17/10 cells, the CD3gamma promoter activity was similar to that of uninfected WE17/10 cells. It was over 2.5 fold of the activity measured for the pGL3 plasmid basic vector (pGL3-BV). The CD3gamma promoter cloned into a plasmid vector was active while the CD3gamma gene transcripts are lost after HTLV-I infection. Thus, after HTLV-I infection, CD3gamma gene silencing could not be explained by a lack of transcription factors but potentially by a restrained accessibility to its transcriptional regulation region.
###end p 51
###begin p 52
###xml 43 46 43 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 0 109 0 105 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Functional analysis by transfection of the <italic>CD3</italic>&#947; promoter activity in HTLV-I infected and uninfected cells</bold>
###xml 166 167 158 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 172 173 160 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 199 200 183 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 205 207 185 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 219 220 195 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 225 227 197 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 297 305 269 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
###xml 342 345 314 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
Functional analysis by transfection of the CD3gamma promoter activity in HTLV-I infected and uninfected cells. Luciferase activity was measured in uninfected CD3gamma+delta+, HTLV-I-infected CD3gamma-delta+ and CD3gamma-delta- WE17/10 cells after 40 h and normalized to activity from the internal Renilla control. Expression of the wild-type CD3gammapromoter constructs (pH gamma3-wt) was measured in comparison to the negative control basic vector: (pGL3-BV) set to one. The pGL3 promoter vector (pGL3-PV) was used as a positive control. The results represent at least three individual experiments, each performed in triplicate.
###end p 52
###begin title 53
Chromatin studies: analysis of DNase I hypersensitivity sites in the CD3gamma/CD3delta gene region
###end title 53
###begin p 54
###xml 10 13 10 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 20 23 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 33 36 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 107 110 93 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 120 123 102 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 264 267 242 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 283 286 257 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 304 307 274 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 343 346 309 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 461 462 419 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 467 469 421 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 552 553 506 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 628 629 582 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 656 658 606 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 663 665 609 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 676 679 622 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 733 736 675 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 828 829 762 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 834 836 764 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human CD3gamma, CD3delta and CD3epsilon genes are located in a 50 kb cluster on chromosome 11q23, with CD3gamma and CD3delta positioned head-to-head and separated by 1.6 kb. DNase I hypersensitivity experiments using probes designed to specifically detect the CD3gamma promoter, CD3delta promoter or CD3delta enhancer (an enhancer for the CD3gamma gene has not been identified yet) revealed that in uninfected (positive control) and HTLV-I infected CD3gamma+delta+ cells all three DNase I hypersensitive sites (DHS) are readily discernible (Figure 3; relative surface CD3 expression and transcript levels are shown in Table 1). In contrast, in CD3gammalodelta+ cells, the CD3gammapromoter DHS site is weakly detectable while the CD3delta promoter and enhancer DHS sites are still clearly evident. In HTLV-I infected CD3gamma-delta- cells, the DHS sites corresponding to all three transcriptional control regions show no open chromatin in this region similar to the B cell line GM-607 used as a negative control. Taken all together our results suggest a potential chromatin remodeling process taking place after HTLV-I infection associated to the CD3 locus silencing.
###end p 54
###begin p 55
###xml 28 31 28 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 41 44 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 0 97 0 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink">DNase I hypersensitivity of <italic>CD3</italic>&#947; and <italic>CD3</italic>&#948; genes regulatory regions after HTLV-I infection</bold>
###xml 185 188 177 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 204 207 192 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 225 228 209 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 412 413 388 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 418 420 390 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 445 446 413 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 451 452 415 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 462 464 422 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 469 470 425 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 484 485 436 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 490 492 438 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 543 544 487 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 549 551 489 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 529 534 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
DNase I hypersensitivity of CD3gamma and CD3delta genes regulatory regions after HTLV-I infection. DNase I hypersensitivity experiments using probes designed to specifically detect the CD3gamma promoter, CD3delta promoter or CD3delta enhancer, indicated on the Y axis. DNA was digested with increasing concentrations of DNase I (increasing from left to right in each panel) and extracted from uninfected CD3gamma+delta+ cells and HTLV-I CD3gamma+delta+, CD3gammalodelta+, and CD3gamma-delta- cells. The B cell (CD3 negative) and HIV-1 CD3gamma-delta+ cell lines were used as controls. The various cell lines are indicated on the X axis. The level of surface TCR/CD3 expression and relative CD3 gene transcripts for each cell line is shown in Table I.
###end p 55
###begin p 56
TCR/CD3 expression in cells used for the DNase I hypersensitivity assay
###end p 56
###begin title 57
Chromatin studies: CHIP experiments
###end title 57
###begin p 58
###xml 5 8 5 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 304 306 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 372 373 364 365 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1</bold>
###xml 372 373 364 365 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><bold>1</bold></sub>
###xml 382 385 370 373 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Inr</bold>
###xml 382 385 370 373 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><bold>Inr</bold></sub>
###xml 386 388 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 451 453 439 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 483 485 471 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 523 525 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 555 564 543 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 634 636 622 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 729 732 717 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 898 900 882 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 952 954 936 938 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 973 975 957 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
The hCD3gamma promoter is lymphoid specific, initiates transcription from multiple start sites, and contains two core promoters capable of recruiting the general transcription machinery through specificity protein (Sp)-binding motifs, with an Initiator (Inr) element present in the primary core promoter[23]. EMSA experiments showed that the complex binding to the Spgamma1/CD3gammaInr[23] wild-type probe was the same in the nuclear extracts from CD3+ uninfected WE17/10 or from CD3- HTLV-I infected WE17/10 cells (Figure 4A). After HTLV-I infection the in vitro binding of transcription factor was apparently not affected in the CD3- HTLV-I infected WE17/10 cells. We analyzed by CHIP the accessibility of the chromatin in the CD3gamma putative promoter area to the transcriptional machinery after HTLV-I infection. An obvious reduction in accessibility for Sp1, Sp3 and TFIID was observed in CD3- HTLV-I infected WE17/10 cells in comparison with CD3+ uninfected (Figure 4B).
###end p 58
###begin p 59
###xml 42 45 42 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 0 82 0 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Transcription factor accessibility to the <italic>CD3</italic>&#947; promoter after HTLV-I infection</bold>
###xml 84 85 80 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 86 95 82 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 117 118 109 110 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1</bold>
###xml 117 118 109 110 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><bold>1</bold></sub>
###xml 127 131 115 119 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Inr </bold>
###xml 127 131 115 119 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><bold>Inr </bold></sub>
###xml 214 216 202 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 247 248 231 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 253 255 233 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 286 287 266 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 361 369 341 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 416 417 392 393 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1</bold>
###xml 416 417 392 393 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><bold>1</bold></sub>
###xml 426 430 398 402 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Inr </bold>
###xml 426 430 398 402 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><bold>Inr </bold></sub>
###xml 446 447 418 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 473 474 441 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 479 481 443 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
Transcription factor accessibility to the CD3gamma promoter after HTLV-I infection. A,In vitro binding to the Spgamma1/CD3gammaInr [22] wild-type probe was examined in EMSA assay using nuclear extracts from TCR/CD3+ uninfected WE17/10 and CD3gamma-delta- HTLV-I infected WE17/10 cells. B, ChIP assay using anti-Sp1, anti-Sp2, anti-Sp3, anti-TFIID, to study the in vivo binding to the sequence surrounding the Spgamma1/CD3gammaInr motif in TCR/CD3+uninfected and in CD3gamma-delta- HTLV-I infected WE17/10 cells.
###end p 59
###begin title 60
###xml 46 48 46 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
Treatment with TSA/AZA rescued CD3 mRNA in CD3- HTLV-I infected WE17/10 cells
###end title 60
###begin p 61
###xml 178 181 178 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 191 194 187 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
Treatment of HTLV-I-infected WE17/10 with the histone deacetylase inhibitor (HDACi) trichostatin A in association with the DNA-methylation inhibitor 5' deoxy-azacytidine rescued CD3gamma and CD3delta transcription as assessed by RT-PCR.
###end p 61
###begin p 62
###xml 161 164 161 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 199 201 195 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 250 252 246 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 290 292 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 353 355 349 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 403 405 399 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 463 465 459 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 506 514 502 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 537 540 533 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 583 585 575 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 616 618 608 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 662 664 654 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
Histone H4 hyperacetylation is a typical feature of active transcription; we therefore analyzed chromatin hyperacetylation as well as the binding of HDAC in the CD3gamma promoter by comparing TCR/CD3+ uninfected, untreated and TSA/AZA treated TCR/CD3- HTLV-I infected WE17/10 cells (Figure 5B). We show that histone hyperacetylation is detectable in CD3+ uninfected WE17/10 cells and TSA/AZA treated CD3- HTLV-I infected WE17/10 cells, but absent in untreated CD3- HTLV-I infected WE17/10 cells. Moreover, in vivo binding of HDAC to the CD3gamma core promoter is more abundant in CD3- HTLV-I infected compared to CD3+ uninfected WE17/10 cells and TSA treated CD3- HTLV-I infected WE17/10 cells.
###end p 62
###begin p 63
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TSA/AZA treatment of HTLV-I infected WE17/10 cells</bold>
###xml 52 53 52 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 103 106 103 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 113 116 109 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 208 209 196 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 214 216 198 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 250 251 230 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 256 259 232 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo </sup>
###xml 378 379 353 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 436 444 411 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 491 492 462 463 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1</bold>
###xml 491 492 462 463 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><bold>1</bold></sub>
###xml 501 505 468 472 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Inr </bold>
###xml 501 505 468 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><bold>Inr </bold></sub>
###xml 514 527 481 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TXP/X&#916;3+ </sup>
###xml 583 584 542 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 589 592 544 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo </sup>
TSA/AZA treatment of HTLV-I infected WE17/10 cells. A, Representative ethidium bromide-stained gels of CD3gamma, CD3delta and GAPDH (endogenous control) RT-PCR products from untreated HTLV-I infected CD3gamma-deltalo, TSA/AZA HTLV-I infected CD3gamma-deltalo (treated for 72 hours with 4 muM of 5'AZA and for 18 hours with 500 nM of TSA) and uninfected untreated WE17/10 cells. B, ChIP assay using anti-Ac-H4 and anti-HDAC to study the in vivo binding to the sequence surrounding the Spgamma1/CD3gammaInr motif in TXP/XDelta3+ uninfected and in untreated and TSA/AZA treated CD3gamma-deltalo HTLV-I infected WE17/10 cells.
###end p 63
###begin title 64
Discussion
###end title 64
###begin p 65
###xml 157 160 157 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 167 170 163 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 177 180 169 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 193 196 179 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 234 236 217 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 272 281 255 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 291 293 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 294 296 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 398 400 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 401 403 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 415 417 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 498 501 481 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 547 549 526 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 624 626 603 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 632 636 611 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 647 648 626 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 649 650 628 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 733 735 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 875 877 854 856 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 391 396 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 409 414 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 562 570 <span type="species:ncbi:9606">patients</span>
###xml 1008 1016 <span type="species:ncbi:9606">patients</span>
The T-cell receptor (TCR)/CD3 complex is the keystone of the antigen-specific immune response. Infection by HTLV-I has been shown to ultimately downregulate CD3gamma, CD3delta, CD3epsilon, and CD3zeta gene transcripts leading to a CD3- surface phenotype after 200 days of in vitro infection[12,13]; however, the sequence of gene loss has not been investigated. We have shown previously that HIV-1 [14-17] and HIV-2[18] associated loss of CD3 expression was characterized by an initial reduction in CD3gamma gene transcripts. Moreover, infected CD4+ T-cells from patients with ATLL are routinely characterized as having a CD3- or CD3low phenotype [7-9]. The viral load and the natural history of HTLV-I has been studied over 10 years[30] in infected individuals. Interestingly, their figures indicate that HTLV-I+ cells have a very weak contribution to the total number of CD3+ cells. Therefore, it is not surprising that some groups did not find a decrease when looking at the total population of T-cells in patients post HTLV-I infection.
###end p 65
###begin p 66
###xml 250 259 250 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 587 590 587 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 431 436 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 448 453 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
In this study, we investigated proviral integration, viral gene expression, CD3 surface density, CD3 gene transcription and chromatin structure over a period of time of three years post HTLV-I infection of the WE17/10 cell line. We found that HTLV-I in vitro infection leads to progressive downmodulation of TCR/CD3 complexes from the cell surface following a pattern of decreasing surface density reminiscent of that observed for HIV-1[14,15] and HIV-2[18], except for its slower kinetics. There is an altered regulation of gene expression affecting initially and more specifically the CD3gamma gene. To ensure that this phenomenon was not restricted to our experimental setting and the utilized cell line, we have tested a number of well-established HTLV-I infected CD4+ cell lines and found a general down modulation of TCR/CD3 surface expression in comparison to their uninfected counterpart.
###end p 66
###begin p 67
###xml 50 53 50 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 66 68 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 69 71 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 365 368 361 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 379 382 371 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 393 396 381 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 412 415 394 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 461 464 440 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 614 616 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1001 1003 976 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1036 1039 1011 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 1132 1134 1103 1105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1234 1237 1205 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 1300 1303 1267 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 1315 1318 1276 1279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 1416 1419 1374 1377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 1426 1429 1380 1383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 1441 1444 1389 1392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 1525 1528 1470 1473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 62 65 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 598 601 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1386 1391 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1584 1589 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
However in contrast to the selective targeting of CD3gamma by HIV[15,18], HTLV-I infection represses in a sequential manner the expression of all four CD3 genes, a distinction obvious at several stages post-infection. Quantification of CD3 gene transcripts in HTLV-I infected cells expressing ~70% of the normal number of surface TCR/CD3 complexes contain only 20% CD3gamma, 48% CD3delta, 62% CD3epsilon and 75% CD3zeta gene transcripts. This extensive loss of CD3gamma transcripts prior to significant TCR/CD3 down-modulation was similar to what we have observed previously for TCR/CD3 loss after HIV-I infection[17]. These data explain why the progression, viewed from the cell surface, appears to be very slow by showing that transcriptional downmodulation is actually initiated early after infection with a considerable and rapid erosion of transcripts until a threshold is reached where the normal number of complete TCR/CD3 complexes can no longer be assembled and exported to the cell surface [31]. Although the complete loss of CD3gamma parallels the receptor negative phenotype in cell lines infected with both viruses, CD3- HTLV-I infected cells continue to progressively loosing expression of the remaining CD3 genes, with CD3delta transcripts being absent at 29 months p.i and about ~25% CD3epsilon and CD3zeta transcripts being still expressed at 3 years p.i. In contrast, HIV-1 infected cells maintain CD3delta, CD3epsilon and CD3zeta transcripts at >75% of normal levels in the presence of steadily decreasing CD3gamma transcripts. Our data thus reveal that while both HIV-1 and HTLV-I target the expression of the CD3 genes, remarkably they appear to accomplish this task with distinct kinetics.
###end p 67
###begin p 68
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 53 56 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Importantly, we also observed that, in contrast with HIV infected cells, an in vitro selection of certain clones occurs, as demonstrated in Fig 1, the cells with the lowest CD3 expression growing more rapidly, as we have observed it by comparing the growth speed of cell frozen at different stage of CD3 expression, then put back in culture (data not shown).
###end p 68
###begin p 69
###xml 10 13 10 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 20 23 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 33 36 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 140 142 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 161 164 147 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 507 510 490 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 517 520 496 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 530 533 505 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 573 576 542 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 651 653 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 670 672 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 709 711 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 728 732 685 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 761 764 718 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 831 834 782 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 844 847 791 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 888 891 831 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 901 904 840 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 941 945 870 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 993 1001 922 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1085 1087 1008 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1161 1164 1084 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 1171 1173 1090 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1178 1181 1097 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 1188 1190 1103 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1260 1264 1175 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3 </italic>
###xml 1320 1324 1235 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 1367 1369 1282 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1392 1396 1307 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 1409 1412 1324 1327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 1472 1475 1381 1384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 1485 1488 1390 1393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 1844 1847 1745 1748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 155 160 <span type="species:ncbi:9606">human</span>
###xml 732 736 <span type="species:ncbi:10090">mice</span>
###xml 945 949 <span type="species:ncbi:10090">mice</span>
The human CD3gamma, CD3delta and CD3epsilon genes, located together on chromosome 11q23, are highly homologous due to their common ancestry[32], while the human CD3zeta gene is located on chromosome 1 and has no apparent sequence homology with the other CD3 genes. It is therefore remarkable that all four genes are sequentially targeted in HTLV-I infected cells. Previous studies investigating the role of individual CD3 chains in thymopoiesis suggest that a mechanism exists for controlling access to the CD3gamma, CD3delta and CD3epsilon gene cluster. Disruption of the CD3epsilon gene by insertion of a neomycin cassette in place of either exon 5[30], exons 5 and 6[33] or the promoter plus exons 1 and 2[34] left CD3epsilon-/- mice who did not only show a CD3epsilon deficiency, but also underwent a significant inhibition of CD3gamma and CD3delta genes transcription. Expression of CD3gamma and CD3delta could be restored in CD3epsilon-/- mice by deletion of the neomycin cassette using in vivo recombination but not by transgenic reconstitution of CD3epsilon protein expression[35]. Furthermore, insertion of the same neomycin cassette in the contiguous CD3gamma [36] or CD3delta [37] genes had no effect on transcription of their other two neighboring CD3 genes. It has been reported that the coding sequence of neo gene can act as a transcriptional silencer[38], which suggests that neo insertion in CD3epsilon potentially functions as an insulator by separating CD3gamma and CD3delta genes from a putative locus control region. Taken altogether, these data indicate the existence of a mechanism for the global control of the 11q23 CD3 genes cluster that is likely to be critical in modulating the expression of these genes during the early stages of T-cell commitment. Similar cellular factors may also be involved in controlling the CD3zeta gene to ensure its coordinate expression with the other CD3 genes during T-cell differentiation and development.
###end p 69
###begin p 70
###xml 52 55 52 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 134 137 130 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 424 427 408 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 437 440 417 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 504 507 480 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 542 545 514 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 666 669 634 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 679 682 643 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
However, by transient transfection we observed that CD3gamma expression could be restored in HTLV-I infected cells lacking endogenous CD3gamma expression. This demonstrates that the loss of CD3gamma is not due to a defect in factors binding to the CD3gamma promoter region and rather suggests a lack of accessibility of these factors to the promoter regions in HTLVI infected cells. We further demonstrated that the loss of CD3gamma and CD3delta transcripts is associated with progressive closure of the CD3gamma promoter DHS followed by the CD3delta promoter and enhancer DHS. Modification in the corresponding DHS occurred in tandem with the reduction and loss of CD3gamma and CD3delta gene expression p.i.
###end p 70
###begin p 71
###xml 35 43 35 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 80 83 80 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 116 118 112 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 174 176 170 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 204 213 200 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 386 388 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 490 492 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
In addition, we showed a reduction in vivo binding of Sp1, Sp3 and TFIID to the CD3gamma core promoter region in CD3- HTLV-I infected WE17/10 cells in comparison with TCR/CD3+ uninfected cells, while the in vitro binding was not affected. It has been shown that Sp1 and Sp3 transcription factor binding to TRE-I repeat III participates in the regulation of HTLV-I viral gene expression[39]. On the other hand, epigenetic mechanisms are responsible of HTLV-I-genes transcriptional silencing[40].
###end p 71
###begin p 72
###xml 142 145 142 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 189 191 185 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 222 224 218 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 486 489 482 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 542 545 534 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 555 558 543 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3</italic>
###xml 574 576 558 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 683 687 667 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3 </italic>
###xml 851 855 835 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD3 </italic>
Histone H4 hyper-acetylation is a typical feature of active transcription. Histone H4 hyperacetylation was reduced and binding of HDAC to the CD3gamma core promoter was more abundant in CD3- HTLV-I infected compared to CD3+ uninfected WE17/10 cells. As expected, treatment with the histone deacetylase inhibitor (HDAC) trichostatin A in association with the DNA-methylation inhibitor 5' deoxy-azacytidine reestablished the H4 hyperacetylation status and reduced the HDAC binding to the CD3gamma core promoter and rescued the transcription of CD3gamma and CD3delta in the CD3- HTLV-I infected. This result reemphasizes that an epigenetic mechanism is at work to downmodulate the four CD3 genes after HTLV-I infection. We recently started a study aiming at unraveling the molecular determinants that coordinate the successive downregulation of the four CD3 genes.
###end p 72
###begin p 73
###xml 69 70 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 117 120 117 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">++ </sup>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
In a previous work we have shown that HTLV-I infection of WE17/10 CD4+cell line leads to progressive alteration of Ca++ influx that eventually results in loss of CD7 expression and activation of an antiapoptotic pathway involving AKT and BAD which paves the way for malignant transformation[10]. Since dysregulation of calcium flux after T-cell activation can be one of the consequences of the lack of TCR/CD3 expression[11] the loss of TCR/CD3 expression could be of significance in the progression of HTLV-1 mediated malignant disease.
###end p 73
###begin title 74
Conclusion
###end title 74
###begin p 75
###xml 300 301 300 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 306 308 306 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
We conclude that HTLV-I expression initiates a process leading to several phenomena, among which a progressive loss of TCR/CD3 by epigenetic mechanisms. These modifications persist after HTLV-I genes are silenced through a mechanism that we have started to investigate. This eventually leads to a CD3-, CD7- phenotype associated with perturbation of calcium fluxes and constitutive activation of PI3 kinase, which prevents apoptosis and augments growth of the infected cells. The mechanism by which these phenomena continue after the loss of viral gene expression will be the subject of further studies, as well as determining whether CD3 progressive loss is an epiphenomenon or a causal event in the process of eventual malignant transformation.
###end p 75
###begin title 76
Abbreviations
###end title 76
###begin p 77
###xml 8 42 <span type="species:ncbi:11908">human T-cell leukemia virus type I</span>
###xml 205 208 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 210 238 <span type="species:ncbi:12721">human immunodeficiency virus</span>
HTLV-I, human T-cell leukemia virus type I; ATL, adult T cell leukemia/lymphoma; NF-kappaB, nuclear factor kappa-B; NFAT, nuclear factor of activated T cell; HBZ, HTLV-I bZIP factor; TCR, T cell receptor; HIV, human immunodeficiency virus; DHS, DNase I hypersensitive site; EF-1-alpha, eukaryotic translation elongation factor1 alpha; MLN51, cancer susceptibility candidate 3.
###end p 77
###begin title 78
Competing interests
###end title 78
###begin p 79
The author(s) declare that they have no competing interests.
###end p 79
###begin title 80
Authors' contributions
###end title 80
###begin p 81
###xml 71 72 71 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 74 75 74 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 77 78 77 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 80 81 80 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 218 219 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
HA conceived this project and carried out most of experiments in Figs. 1, 2, 3, 4. BB participated in the design of the study and performed the CHIP experiments. GD carried out the DNase hypersensitivity assays in fig 5. GM participated to the Real time RT-PCR experiments. MMoschitta participated in the constructs of the plasmid used in the transfection assay. MMerimi contributed to the TSA/AZA treatment assay. AB, PM and KW participated in the study design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
###end p 81
###begin title 82
Supplementary Material
###end title 82
###begin title 83
Additional file 1
###end title 83
###begin p 84
###xml 217 219 217 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 225 229 225 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
CD3 expression on the surface of HTLV-I-infected cells. We have tested the HTLV-I infected cell lines MT-2, C91, WE/HTLV and an ATLL derived cell line PaBe for their TCR/CD3 surface expression. All the cells had a CD3- or CD3low phenotype.
###end p 84
###begin p 85
Click here for file
###end p 85
###begin title 86
Acknowledgements
###end title 86
###begin p 87
We thank the Belgian Fonds National de la Recherche Scientifique (FNRS and Televie), Friends of the Bordet Institute, and Fonds David and Alice Van Buuren for their support. Haidar AKL is a FNRS scientific collaborator. Bassam Badran is a FNRS post-doctoral researcher.
###end p 87
###begin article-title 88
###xml 29 63 <span type="species:ncbi:11908">human T-cell leukemia virus type I</span>
Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF-kappa B
###end article-title 88
###begin article-title 89
###xml 108 113 <span type="species:ncbi:9606">human</span>
Exclusive ubiquitination and sumoylation on overlapping lysine residues mediate NF-kappaB activation by the human T-cell leukemia virus tax oncoprotein
###end article-title 89
###begin article-title 90
Tax ubiquitylation and sumoylation control critical cytoplasmic and nuclear steps of NF-kappaB activation
###end article-title 90
###begin article-title 91
###xml 53 86 <span type="species:ncbi:11908">human T-lymphotropic virus type 1</span>
Activation of nuclear factor of activated T cells by human T-lymphotropic virus type 1 accessory protein p12(I)
###end article-title 91
###begin article-title 92
###xml 41 46 <span type="species:ncbi:9606">human</span>
A conserved calcineurin-binding motif in human T lymphotropic virus type 1 p12I functions to modulate nuclear factor of activated T cell activation
###end article-title 92
###begin article-title 93
HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein
###end article-title 93
###begin article-title 94
Flow cytometric immunophenotyping of adult T-cell leukemia/lymphoma using CD3 gating
###end article-title 94
###begin article-title 95
Specific decrease in T3 antigen density in adult T-cell leukaemia cells: I. Flow microfluorometric analysis
###end article-title 95
###begin article-title 96
T3 surface molecules on adult T cell leukemia cells are modulated in vivo
###end article-title 96
###begin article-title 97
HTLV-I infection of WE17/10 CD4+ cell line leads to progressive alteration of Ca2+ influx that eventually results in loss of CD7 expression and activation of an antiapoptotic pathway involving AKT and BAD which paves the way for malignant transformation
###end article-title 97
###begin article-title 98
Immunodeficiency with low expression of the T cell receptor/CD3 complex. Effect on T lymphocyte activation
###end article-title 98
###begin article-title 99
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human T cell leukemia/lymphoma virus type I infection of a CD4+ proliferative/cytotoxic T cell clone progresses in at least two distinct phases based on changes in function and phenotype of the infected cells
###end article-title 99
###begin article-title 100
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human T cell leukemia virus type I prevents cell surface expression of the T cell receptor through down-regulation of the CD3-gamma, -delta, -epsilon, and -zeta genes
###end article-title 100
###begin article-title 101
###xml 117 145 <span type="species:ncbi:12721">human immunodeficiency virus</span>
A specific defect in CD3 gamma-chain gene transcription results in loss of T-cell receptor/CD3 expression late after human immunodeficiency virus infection of a CD4+ T-cell line
###end article-title 101
###begin article-title 102
###xml 46 49 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Modulation of CD3-gamma gene expression after HIV type 1 infection of the WE17/10 T cell line is progressive and occurs in concert with decreased production of viral p24 antigen
###end article-title 102
###begin article-title 103
###xml 51 56 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Down-modulation of TCR/CD3 surface complexes after HIV-1 infection is associated with differential expression of the viral regulatory genes
###end article-title 103
###begin article-title 104
###xml 77 82 <span type="species:ncbi:9606">human</span>
Identification of three NFAT binding motifs in the 5'-upstream region of the human CD3gamma gene that differentially bind NFATc1, NFATc2, and NF-kappa B p50
###end article-title 104
###begin article-title 105
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 113 118 <span type="species:ncbi:9606">Human</span>
Human Immunodeficiency Virus Type 2 Produces a Defect in CD3-gamma Gene Transcripts Similar to That Observed for Human Immunodeficiency Virus Type 1
###end article-title 105
###begin article-title 106
Defective CD3gamma gene transcription is associated with NFATc2 overexpression in the lymphocytic variant of hypereosinophilic syndrome
###end article-title 106
###begin article-title 107
###xml 27 62 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Differential activation of human immunodeficiency virus type 1 and 2 transcription by specific T-cell activation signals
###end article-title 107
###begin article-title 108
###xml 78 83 <span type="species:ncbi:9606">human</span>
###xml 104 109 <span type="species:ncbi:9606">human</span>
Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells
###end article-title 108
###begin article-title 109
###xml 34 40 <span type="species:ncbi:10090">Murine</span>
T Cell-specific Expression of the Murine CD3delta Promoter
###end article-title 109
###begin article-title 110
###xml 34 39 <span type="species:ncbi:9606">Human</span>
Transcriptional Regulation of the Human CD3{gamma} Gene: The TATA-Less CD3{gamma} Promoter Functions via an Initiator and Contiguous Sp-Binding Elements
###end article-title 110
###begin article-title 111
Identification of DNaseI hypersensitive sites within nuclei
###end article-title 111
###begin article-title 112
Failure to synthesize the CD3-gamma chain. Consequences for T cell antigen receptor assembly, processing, and expression
###end article-title 112
###begin article-title 113
###xml 49 54 <span type="species:ncbi:9606">human</span>
CD3 gamma, CD3 delta, and CD3 zeta mRNA in adult human marrow hematopoietic progenitors correlates with surface CD2 and CD7 expression
###end article-title 113
###begin article-title 114
Identification and validation of endogenous reference genes for expression profiling of T helper cell differentiation by quantitative real-time RT-PCR
###end article-title 114
###begin article-title 115
A T cell-specific enhancer is located in a DNase I-hypersensitive area at the 3' end of the CD3-delta gene
###end article-title 115
###begin article-title 116
De novo reverse transcription of HTLV-1 following cell-to-cell transmission of infection
###end article-title 116
###begin article-title 117
###xml 24 29 <span type="species:ncbi:9606">human</span>
Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data
###end article-title 117
###begin article-title 118
Some hints concerning the shape of T-cell receptor structures
###end article-title 118
###begin article-title 119
Evidence for a stepwise evolution of the CD3 family
###end article-title 119
###begin article-title 120
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Altered T cell development in mice with a targeted mutation of the CD3-epsilon gene
###end article-title 120
###begin article-title 121
Specific requirement for CD3epsilon in T cell development
###end article-title 121
###begin article-title 122
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Expression of a CD3 epsilon transgene in CD3 epsilon(null) mice does not restore CD3 gamma and delta expression but efficiently rescues T cell development from a subpopulation of prothymocytes
###end article-title 122
###begin article-title 123
The CD3gamma chain is essential for development of both the TCRalphabeta and TCRgammadelta lineages
###end article-title 123
###begin article-title 124
CD3 delta deficiency arrests development of the alpha beta but not the gamma delta T cell lineage
###end article-title 124
###begin article-title 125
The prokaryotic neomycin-resistance-encoding gene acts as a transcriptional silencer in eukaryotic cells
###end article-title 125
###begin article-title 126
###xml 14 48 <span type="species:ncbi:11908">human T-cell leukemia virus type 1</span>
Regulation of human T-cell leukemia virus type 1 gene expression by Sp1 and Sp3 interaction with TRE-1 repeat III
###end article-title 126
###begin article-title 127
###xml 13 47 <span type="species:ncbi:11908">human T-cell leukemia virus type I</span>
Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms
###end article-title 127

